Franklin Resources’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $30.2M | Buy |
593,596
+241
| +0% | +$12.3K | 0.01% | 794 |
|
|
2025
Q1 | $26.7M | Buy |
593,355
+2,693
| +0.5% | +$121K | 0.01% | 813 |
|
|
2024
Q4 | $24.4M | Sell |
590,662
-1,994
| -0.3% | -$82.5K | 0.01% | 835 |
|
|
2024
Q3 | $23.6M | Sell |
592,656
-348,914
| -37% | -$13.9M | 0.01% | 847 |
|
|
2024
Q2 | $32.2M | Buy |
941,570
+196
| +0% | +$6.7K | 0.01% | 700 |
|
|
2024
Q1 | $23.6M | Buy |
941,374
+28,306
| +3% | +$711K | 0.01% | 813 |
|
|
2023
Q4 | $27M | Buy |
913,068
+168,446
| +23% | +$4.97M | 0.01% | 681 |
|
|
2023
Q3 | $23.5M | Buy |
744,622
+133,541
| +22% | +$4.22M | 0.01% | 700 |
|
|
2023
Q2 | $15.8M | Buy |
611,081
+210,579
| +53% | +$5.45M | 0.01% | 829 |
|
|
2023
Q1 | $9.62M | Buy |
400,502
+20
| +0% | +$480 | ﹤0.01% | 938 |
|
|
2022
Q4 | $7.81M | Sell |
400,482
-1,135,642
| -74% | -$22.1M | ﹤0.01% | 1006 |
|
|
2022
Q3 | $32.3M | Buy |
1,536,124
+287,002
| +23% | +$6.03M | 0.02% | 646 |
|
|
2022
Q2 | $24.3M | Buy |
1,249,122
+578
| +0% | +$11.2K | 0.01% | 744 |
|
|
2022
Q1 | $27.5M | Buy |
1,248,544
+764,441
| +158% | +$16.8M | 0.01% | 768 |
|
|
2021
Q4 | $7.72M | Buy |
+484,103
| New | +$7.72M | ﹤0.01% | 1119 |
|